May #112 : Ducking Resistance - by Laura Whitehorn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

A Model Activist

Hep Cat

The Brave Lady of Haiti

Mighty Real

Big, Bad Media Bugout

Earthwatch

PEP on the Down Low

Quick Studies

Legal Eye

On the March!

Notes on Camp

Kentucky Fried Bigots?

POZ Picks

Hollywood to HIVers: Drop Dead

Ouch!

Veggie Table

Don't Run

A Peek in the Pipeline

Ducking Resistance

Quick Study

Pharm Team

Warning!

Haartbeats

Editor's Letter

Mailbox

Teen Jeopardy

Heavy Lifting



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

May 2005

Ducking Resistance

by Laura Whitehorn

“Rutgers researchers may have stopped HIV,” AP headlines hyped last December.

HIV treatment pros didn’t jump at the news, because it’s only half true: Many new HIV meds have “unique” resistance profiles and can overcome the resistance HIV develops to older meds in their class—but they’re vulnerable to new HIV mutations. The Rutgers non-nuke innovation—DAPY, for di-aryl-pyrimidine derivatives—promises to “wiggle” around resistance: If HIV mutations prevent meds from blocking one point on a key enzyme, DAPYs can adapt, blocking others. A med that can do this would be wildly welcome, as even newly diagnosed HIVers learn to live with drug-resistant virus.

Treatment activists are guardedly hopeful. “TMC-125, the DAPY that’s reached Phase II trials, seems to be performing well in folks with non-nuke resistance,” says Tim Horn. “But we still don't know” how they’ll fare over the longer run, he adds. To the wiggle room.  



[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.